---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027541"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:26:40.330540+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences raises $3.1M via warrant exercise inducement at $7.05 per share

## Summary
- Gross proceeds of ~$3.1M from cash exercise of 426,390 existing warrants at reduced price of $7.05/sh.
- Issued new Series E warrants (5-yr term) and Series F warrants (18-mo term) for up to 426,390 shares each at $7.05.
- H.C. Wainwright served as placement agent; fees of 7.0% of gross proceeds plus placement agent warrants.
- Net proceeds allocated to product development, working capital, and general corporate purposes.
- Company to file resale registration statement for new warrant shares within 10 days.

## SEC filing metadata
- accession: 0001493152-25-027541
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225027541/0001493152-25-027541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225027541/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027541
- JSON: https://secwatch.observer/filing/0001493152-25-027541.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.